NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 197 filers reported holding NEVRO CORP in Q3 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,284,000 | +73.7% | 49,012 | +63.4% | 0.10% | +74.5% |
| Q2 2022 | $1,315,000 | -87.6% | 30,000 | -79.5% | 0.06% | -86.0% |
| Q1 2022 | $10,609,000 | +175.8% | 146,674 | +209.1% | 0.39% | +133.1% |
| Q4 2021 | $3,847,000 | +0.8% | 47,457 | +44.7% | 0.17% | -9.6% |
| Q3 2021 | $3,816,000 | +197.2% | 32,786 | +205.0% | 0.19% | +27.2% |
| Q2 2020 | $1,284,000 | -28.3% | 10,750 | -29.4% | 0.15% | -21.4% |
| Q4 2019 | $1,790,000 | – | 15,225 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |